Skip to content
Search

Latest Stories

GPhC to consult on new registration route for international pharmacists in 2025

GPhC to consult on new registration route for international pharmacists in 2025
"Our Council has listened and decided to propose one single route for all non-EEA/EFTA internationally-qualified pharmacists," Duncan Rudkin, Chief Executive of the GPhC, announced.

In response to stakeholder feedback, the General Pharmaceutical Council (GPhC) is developing a streamlined, single route to registration that will replace the current multiple-pathway system for overseas pharmacists wishing to practice in Great Britain.

This revised approach will include updated standards for the education and training of internationally qualified pharmacists, with all applicants still required to pass a registration assessment.


The GPhC's Council intends to streamline the registration pathway, reducing the two-year process to one-year process.

This new pathway will encompass both university study and in-practice training.

Historically, pharmacists qualified within the European Economic Area (EEA) or European Free Trade Association (EFTA) have been eligible for qualification recognition in Great Britain.

While this recognition has been extended until September 2028, the future requirement for EEA-qualified pharmacists to undergo the new registration route remains contingent on forthcoming government decisions.

Initially, the GPhC had explored the development of three distinct registration routes for internationally-qualified pharmacists, "however decided to change this proposed approach after considering feedback from stakeholders."

The extensive feedback highlighted concerns regarding fairness and inclusivity in the original proposal, leading to a reassessment and the decision to pursue a unified, one-year pathway.

Duncan Rudkin, Chief Executive of the GPhC, emphasised the Council's commitment to equality, diversity, and inclusivity.

"While stakeholders generally welcomed the reduction in time and cost, concerns were raised about fairness.

Additionally, Rudkin stated that the GPhC would also be focusing their efforts "at this point on taking forward the one-year programme, because a significant proportion of overseas applicants are applying from countries such as India, Pakistan and Nigeria, who would need to complete a one-year programme.

“We also intend that shortening the course from two years to one year, once implemented, will significantly reduce the burden for internationally-qualified pharmacists and help to increase the pharmacist workforce in the long-term"

Looking ahead, the GPhC will further refine the details of this proposed approach, alongside drafting updated standards for the education and training of internationally-qualified pharmacists.

A public consultation on these proposals is slated for 2025, with the changes to the Overseas Pharmacists Assessment Programme (OSPAP) expected no earlier than September 2026.

In addition to this, the GPhC is considering a similar review for internationally-qualified pharmacy technicians, focusing on a shorter registration route based on prior learning.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less